|
Atomistry » Chlorine » PDB 5hi6-5hq4 » 5hm0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Chlorine » PDB 5hi6-5hq4 » 5hm0 » |
Chlorine in PDB 5hm0: Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3Protein crystallography data
The structure of Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3, PDB code: 5hm0
was solved by
H.Jayaram,
F.Poy,
J.W.Setser,
S.F.Bellon,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3
(pdb code 5hm0). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3, PDB code: 5hm0: Chlorine binding site 1 out of 1 in 5hm0Go back to![]() ![]()
Chlorine binding site 1 out
of 1 in the Crystal Structure of the First Bromodomain of Human BRD4 Bound to Benzoisoxazoloazepine 3
![]() Mono view ![]() Stereo pair view
Reference:
B.K.Albrecht,
V.S.Gehling,
M.C.Hewitt,
R.G.Vaswani,
A.Cote,
Y.Leblanc,
C.G.Nasveschuk,
S.Bellon,
L.Bergeron,
R.Campbell,
N.Cantone,
M.R.Cooper,
R.T.Cummings,
H.Jayaram,
S.Joshi,
J.A.Mertz,
A.Neiss,
E.Normant,
M.O'meara,
E.Pardo,
F.Poy,
P.Sandy,
J.Supko,
R.J.Sims,
J.C.Harmange,
A.M.Taylor,
J.E.Audia.
Identification of A Benzoisoxazoloazepine Inhibitor (Cpi-0610) of the Bromodomain and Extra-Terminal (Bet) Family As A Candidate For Human Clinical Trials. J.Med.Chem. V. 59 1330 2016.
Page generated: Fri Jul 26 08:54:13 2024
ISSN: ISSN 0022-2623 PubMed: 26815195 DOI: 10.1021/ACS.JMEDCHEM.5B01882 |
Last articlesCl in 5BKCCl in 5BKB Cl in 5BMS Cl in 5BJZ Cl in 5BK1 Cl in 5B6B Cl in 5B7B Cl in 5B66 Cl in 5B82 Cl in 5B74 |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |